Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: 675 nm Red Touch Laser Therapy: power 1 W, dwell time 100 ms, stack 1, spacing 1000 µm, cooling at 15 °C, and 13×13 mm scanning area. Three passes over the transplanted scalp area are p
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Patient Diagnosed with AGA, who underwent Hair Transplantation 1 month back. With or without prior history of treatment currently on oral minoxidil and peptides Age 18 to 70 years Male and females Norwood Grade IV- VI(Males) / Ludwig – I-II (Females)
Exclusion criteria
Exclusion criteria: Active scalp infections Systemic Diseases Affecting Hair (Example Thyroid, Anaemia) Hypersensitivity To PRP/Laser (photosensitive disorders)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hair density (hairs/cm²) and hair thickness (µm) in the transplanted area, measured by trichoscopic imaging (FotoFinder) from baseline to 6 months post-treatment.Timepoint: After 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| include improvement in anagen/telogen and terminal/vellus hair ratios, reduction in hair fall assessed by the hair pull test, and patient satisfaction measured using a Visual Analogue Scale (VAS 0–10). Physician Global Assessment (PGA) will be recorded at 3 and 6 months post-treatment. Safety and tolerability will be evaluated by documenting any adverse events such as pain, erythema, edema, or folliculitis throughout the study period.Timepoint: After 6 months | — |
Countries
India
Contacts
Public ContactDr Priya Prem
CUTIS Academy of Cutaneous Sciences
Outcome results
None listed